• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞适配蛋白通过PI3K/AKT信号通路促进膀胱癌的增殖、转移和血管生成。

Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway.

作者信息

Hou Teng, Zhou Lijie, Wang Longwang, Kazobinka Gallina, Chen Yumao, Zhang Xiaoping, Chen Zhaohui

机构信息

Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Urology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

出版信息

Cell Physiol Biochem. 2018;47(6):2250-2260. doi: 10.1159/000491536. Epub 2018 Jul 5.

DOI:10.1159/000491536
PMID:29975926
Abstract

BACKGROUND/AIMS: Leupaxin (LPXN) is a member of the paxillin protein family. Several studies have reported that LPXN regulates cancer development; however, the role of LPXN in bladder cancer remains unknown.

METHODS

The expression of LPXN in bladder cancer cells and tissues was determined by real-time PCR, western blotting, and immunohistochemistry, respectively. The biological role of LPXN in bladder cancer cell proliferation, invasion, and angiogenesis was explored both in vitro and in vivo.

RESULTS

LPXN expression was elevated in bladder cancer tissues and cell lines compared to adjacent non-tumor tissues and normal urothelial cells. High LPXN expression was correlated with large tumor size, advanced tumor stage, and poor survival in bladder cancer patients. Overexpression of LPXN significantly promoted the proliferation, invasion, and angiogenesis of bladder cancer cells, while suppressing LPXN had the opposite effects. The impact on tumor progression was abolished by inhibiting PI3K/ AKT signaling pathway. We further demonstrated that LPXN probably up-regulated S100P via the PI3K/AKT pathway.

CONCLUSIONS

LPXN may facilitate bladder cancer progression by upregulating the expression of S100P via PI3K/AKT pathway. These results provide a novel insight into the role of LPXN in tumorigenesis and progression of bladder cancer and potential therapeutic target of bladder cancer.

摘要

背景/目的:白细胞适配蛋白(LPXN)是桩蛋白家族的成员。多项研究报道LPXN可调节癌症发展;然而,LPXN在膀胱癌中的作用尚不清楚。

方法

分别通过实时聚合酶链反应、蛋白质免疫印迹法和免疫组织化学法检测LPXN在膀胱癌细胞和组织中的表达。在体外和体内探究LPXN在膀胱癌细胞增殖、侵袭及血管生成中的生物学作用。

结果

与相邻非肿瘤组织和正常尿路上皮细胞相比,LPXN在膀胱癌组织和细胞系中的表达升高。LPXN高表达与膀胱癌患者的肿瘤体积大、肿瘤分期晚及生存率低相关。LPXN过表达显著促进膀胱癌细胞的增殖、侵袭及血管生成,而抑制LPXN则产生相反作用。抑制PI3K/AKT信号通路可消除对肿瘤进展的影响。我们进一步证明,LPXN可能通过PI3K/AKT途径上调S100P的表达。

结论

LPXN可能通过PI3K/AKT途径上调S100P的表达促进膀胱癌进展。这些结果为LPXN在膀胱癌发生发展中的作用及膀胱癌潜在治疗靶点提供了新的见解。

相似文献

1
Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway.白细胞适配蛋白通过PI3K/AKT信号通路促进膀胱癌的增殖、转移和血管生成。
Cell Physiol Biochem. 2018;47(6):2250-2260. doi: 10.1159/000491536. Epub 2018 Jul 5.
2
Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.微小RNA-135a通过IGF-1/PI3K/Akt信号通路对非小细胞肺癌细胞增殖、迁移、侵袭、凋亡及肿瘤血管生成的影响
Cell Physiol Biochem. 2017;42(4):1431-1446. doi: 10.1159/000479207. Epub 2017 Jul 17.
3
Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.血管生成素与核糖核酸酶抑制剂相互作用,调节膀胱癌细胞中的PI3K/AKT/mTOR信号通路。
Cell Signal. 2014 Dec;26(12):2782-92. doi: 10.1016/j.cellsig.2014.08.021. Epub 2014 Sep 2.
4
Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.前列腺癌细胞中Pyk2和PTP-PEST与leupaxin的相互作用。
Am J Physiol Cell Physiol. 2007 Jun;292(6):C2288-96. doi: 10.1152/ajpcell.00503.2006. Epub 2007 Feb 28.
5
CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.CAV-1通过诱导上皮-间质转化促进膀胱癌进展。
Urol Oncol. 2014 Aug;32(6):855-63. doi: 10.1016/j.urolonc.2014.01.005. Epub 2014 Jun 23.
6
BHLHE41 inhibits bladder cancer progression via regulation of PYCR1 stability and thus inactivating PI3K/AKT signaling pathway.BHLHE41 通过调节 PYCR1 的稳定性来抑制膀胱癌的进展,从而使 PI3K/AKT 信号通路失活。
Eur J Med Res. 2024 May 29;29(1):302. doi: 10.1186/s40001-024-01889-2.
7
Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon.白细胞整合素激活蛋白通过调节肌动蛋白结合蛋白钙调蛋白的磷酸化状态来刺激前列腺癌细胞的黏附和迁移。
Oncotarget. 2015 May 30;6(15):13591-606. doi: 10.18632/oncotarget.3792.
8
[Molecular mechanisms of leupaxin involved in prostate carcinoma metastasis].[亮氨酸富含重复序列和 PDZ 结构域蛋白参与前列腺癌转移的分子机制]
Zhonghua Nan Ke Xue. 2013 Jun;19(6):555-8.
9
MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.微小RNA-608通过AKT/FOXO3a信号通路抑制膀胱癌的增殖。
Mol Cancer. 2017 May 26;16(1):96. doi: 10.1186/s12943-017-0664-1.
10
PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.过氧化物酶体增殖物激活受体 γ 的激活可通过抑制 PI3K-Akt 信号通路抑制膀胱癌,成为一种治疗策略。
BMC Cancer. 2019 Mar 7;19(1):204. doi: 10.1186/s12885-019-5426-6.

引用本文的文献

1
Multiple roles of S100P in pan carcinoma: Biological functions and mechanisms (Review).S100P在泛癌中的多重作用:生物学功能与机制(综述)
Oncol Rep. 2025 Jun;53(6). doi: 10.3892/or.2025.8895. Epub 2025 Apr 11.
2
Mechanistic insights into PROS1 inhibition of bladder cancer progression and angiogenesis via the AKT/GSK3β/β-catenin pathway.关于PROS1通过AKT/GSK3β/β-连环蛋白途径抑制膀胱癌进展和血管生成的机制性见解。
Sci Rep. 2025 Feb 8;15(1):4748. doi: 10.1038/s41598-025-89217-4.
3
Development and validation of a glycolysis-associated gene signature for predicting the prognosis, immune landscape, and drug sensitivity in bladder cancer.
用于预测膀胱癌预后、免疫格局和药物敏感性的糖酵解相关基因特征的开发与验证
Front Immunol. 2025 Jan 10;15:1430583. doi: 10.3389/fimmu.2024.1430583. eCollection 2024.
4
STAT3 mediates ECM stiffness-dependent progression in ovarian cancer.信号转导和转录激活因子3(STAT3)介导卵巢癌中细胞外基质(ECM)硬度依赖性进展。
Mol Cell Biochem. 2025 Jan;480(1):607-620. doi: 10.1007/s11010-024-04991-5. Epub 2024 Apr 16.
5
A Potential biomarker for the early diagnosis of OSCC: saliva and serum PrP.一种用于口腔鳞状细胞癌早期诊断的潜在生物标志物:唾液和血清中的朊蛋白。
J Cancer. 2024 Jan 21;15(6):1593-1602. doi: 10.7150/jca.92489. eCollection 2024.
6
Proteomic analysis of holocarboxylase synthetase deficient-MDA-MB-231 breast cancer cells revealed the biochemical changes associated with cell death, impaired growth signaling, and metabolism.全羧化酶合成酶缺陷型MDA-MB-231乳腺癌细胞的蛋白质组学分析揭示了与细胞死亡、生长信号受损及代谢相关的生化变化。
Front Mol Biosci. 2024 Jan 11;10:1250423. doi: 10.3389/fmolb.2023.1250423. eCollection 2023.
7
Construction and validation of a cuproptosis-related lncRNA prognosis signature in bladder carcinoma.构建并验证膀胱癌中与铜死亡相关的 lncRNA 预后特征。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11207-11221. doi: 10.1007/s00432-023-05013-5. Epub 2023 Jun 24.
8
An Overview of Angiogenesis in Bladder Cancer.膀胱癌中的血管生成概述。
Curr Oncol Rep. 2023 Jul;25(7):709-728. doi: 10.1007/s11912-023-01421-5. Epub 2023 Apr 13.
9
Identification of Paxillin as a Prognostic Factor for Glioblastoma via Integrated Bioinformatics Analysis.通过整合生物信息学分析鉴定 Paxillin 作为胶质母细胞瘤的预后因素。
Biomed Res Int. 2022 Jun 23;2022:7171126. doi: 10.1155/2022/7171126. eCollection 2022.
10
MicroRNA-200c affects bladder cancer angiogenesis by regulating the Akt2/mTOR/HIF-1 axis.微小RNA-200c通过调节Akt2/ mTOR/ HIF-1轴影响膀胱癌血管生成。
Transl Cancer Res. 2019 Dec;8(8):2713-2724. doi: 10.21037/tcr.2019.10.23.